Pure Global AI
NCT06325410Completed

Prognostic Factors Influencing the Recurrence Rate and Survival of Patients With Colorectal Cancer: a Single Institution Experience

Zagazig UniversityClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Colorectal Cancer
Drug/Device/Intervention
resection of colorectal cancer
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Zagazig University
Location
Zagazig, Egypt
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2013
End date
Dec 01, 2022
Enrollment
200 participants
Primary outcome

age,sex,medical disease,previous surgery,CEA,tumor grade,tumor site,tumor size,surgical margins of resected tumor,neoadjuvant therapy,adjuvant therapy,diet,occupation,family history,type of surgery(laparoscopic or open),soiling by during surgery,hand sewen or stappled anastmosis,post operative complications,site of recurrence,type of resected tumor

Summary

over the past decade colon cancer has emerged as the second most deadly and the third most
 common type of cancer in the world with increasing incidence in Egypt due to life style and
 diet change. some research showed relation between colon cancer recurrence and advanced tumor
 staging. To investigators knowledge, this is the first time to be done in Zagazig University.
 
 Data was collected from records in a retrospective cohort study

ICD-10 classifications
Malignant neoplasm of colonMalignant neoplasm: Descending colonMalignant neoplasm: Colon, unspecifiedMalignant neoplasm: Ascending colonMalignant neoplasm: Overlapping lesion of colon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06325410
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06325410 through Pure Global AI's free database. This phase not specified trial is sponsored by Zagazig University and is currently Completed. The study focuses on Colorectal Cancer. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.